Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 19Ovarian Neoplasms 12Fallopian Tube Neoplasms 9Stomach Neoplasms 4Vulvar Neoplasms 3Vaginal Neoplasms 2Peritoneal Neoplasms 2Mesothelioma, Malignant 2Carcinoma, Ovarian Epithelial 2Brenner Tumor 2Vomiting 1Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Sertoli-Leydig Cell Tumor 1Sarcoma 1Rhabdomyosarcoma 1Recurrent Uterine Corpus Carcinoma 1Rectal Neoplasms 1Prostatic Neoplasms 1Penile Neoplasms 1Pelvic Neoplasms 1Ovarian gynandroblastoma 1Neoplasm Metastasis 1Nausea 1Lung Neoplasms 1Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified 1Locally Advanced Cervical Carcinoma 1Locally Advanced Cervical Adenocarcinoma 1Liposarcoma 1HIV Infections 1

Interventions

Radiotherapy 1Radiation 1Platinum 1Cisplatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified × Platinum × Gynecologic × Clear all
NCT04580771 2026-04-15

A Vaccine (PDS0101) and Chemoradiation for the Treatment of Stage IB3-IVA Cervical Cancer, the IMMUNOCERV Trial

M.D. Anderson Cancer Center

Phase 2 Active not recruiting
22 enrolled
Gynecologic

Locally Advanced Cervical Squamous Cell Carcinoma, Not Otherwise Specified

Data powered by HemOnc (CC BY 4.0) Colophon âš¡